Listar por tema "Cabergoline"

Mostrando ítems 1-2 de 2

    • Effect of cabergoline on tumor remnant after surgery in nonfunctioning pituitary adenoma 

      Iglesias, Pedro; Biagetti, Betina; Araújo-Castro, Marta; Alcázar, Victoria; Guerrero-Pérez, Fernando; Rivero, Noelia; Casteràs, Anna; García Izquierdo, Belén; García Gómez, Carlos; Viedma Torres, Víctor; Pascual-Corrales, Eider; Pavón, Isabel; Villabona, Carles; Cordido, Fernando; Díez, Juan J. (Springer, 2022-11-10)
      [Abstract] Background: In recent years, dopamine agonists (DAs) have become an attractive therapeutic option to prevent both tumor growth and post-surgical tumor remnant growth in clinically non-functioning pituitary adenoma ...

    • Use of lanreotide in combination with cabergoline or pegvisomant in patients with acromegaly in the clinical practice: the ACROCOMB study 

      Puig-Domingo, Manuel; Soto, Alfonso; Venegas, Eva; Vílchez, Ricardo; Blanco, Concepción; Cordido, Fernando; Lucas, Tomás; Marazuela, Mónica; Casany, Rosa; Cuatrecasas, Guillem; Fajardo, Carmen; Gálvez, María Ángeles; Maraver, Silvia; Martín, Tomás; Romero, Enrique; Paja, Miguel; Picó, Antonio; Bernabéu, Ignacio; Resmini, Eugenia (Elsevier, 2016-11-04)
      [Abstract] PURPOSE: To describe real-world use of lanreotide combination therapy for acromegaly. PATIENTS AND METHODS: ACROCOMB is a retrospective observational Spanish study of patients with active acromegaly treated ...